Alnylam Pharmaceuticals
ALNY
#798
Rank
C$44.81 B
Marketcap
C$334.92
Share price
1.69%
Change (1 day)
-45.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company